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Stem cells (SCs), undifferentiated elements able to acquire specific phenotype upon 
stimulation, represent an important source for regenerative medicine, restoring function 
of compromised organs. The purpose of regenerative biology is to identify the cellular 
and molecular differences that distinguish normal tissue turnover from scar repair, in 
order to create an ideal microenvironment suitable for regeneration in damaged adult 
tissues. Stem cell differentiation is a complex process controlled by signaling pathways 
and molecular mechanisms, acting to maintain tissue homeostasis. A wide range of 
natural molecules and compounds, known as nutraceuticals or functional foods, are 
widely used for their therapeutic or preventive effects. These natural and synthetic 
molecules exert their action via epigenetic modulations of a specific molecular 
differentiation program and gene expression of lineage-specific markers. Within this 
context, unraveling the cellular mechanisms involved in the activation and 
differentiation of the adipose resident stem cells, could help in identifying innovative 
and preventive tools to counteract obesity and its related diseases. The aim of this 
project was to evaluate cell behavior in the presence of conditioned media, drugs or 
natural molecules, in the attempt to counteract the molecular mechanisms involved in 
inflammatory-associated adipogenesis. Understanding the molecular mechanisms 
involved in the decision of this fate could lead to the development of drugs capable of 
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Regenerative medicine identifies the area of research and therapies based on the use of 
stem cells for tissue regeneration 
[1]
. Several diseases lead to loss of functionality or 
aging of tissues and organs 
[2]
. In the last years, the interest of researchers has been 
oriented toward regenerative medicine, with the aim of restoring function of 
compromised organs 
[3]
. The aim of regenerative biology is to identify the cellular and 
molecular differences that distinguish normal tissue turnover from scar repair, in order 
to create an ideal microenvironment suitable for regeneration in damaged adult tissue 
[4][5]
. Regenerative medicine encompasses a set of interdisciplinary activities, including 
the possibility of inserting growth factors in the damaged site, or alternatively the 
development of biomaterials for tissue engineering 
[5]
. Most of these, as biomimetic 
polymers and bioactive three-dimensional scaffolds, are capable of inducing specific 
cellular responses and the formation of new tissues to be implanted in vivo 
[6][7]
. Stem 
cells (SCs) represent an important source for regenerative medicine, to ameliorate 
genetic and degenerative diseases, as cardiovascular, musculoskeletal and neurological 
[8][9]
. To be considered ideal for tissue regeneration, SCs must be easily expandable in 
vitro, multipotent and able to permanently restore tissue function avoiding neoplastic 
transformation 
[10][11]
. The extra cellular matrix (ECM) plays a crucial role in stem cell 
differentiation 
[12]
. External stimuli coming from the microenvironment in which they 
reside, known as niche, finely regulate stem cell fate in order to maintain homeostasis 
and remodel tissues in physiological and pathological conditions 
[13][14]
. SCs could then 
be harnessed for patients with serious disease, with a high yield and minimizing the risk 
of rejection 
[15][16]
. Transplantation of bone marrow-derived SCs has been applied for 
the treatment of celiac disease and chronic inflammatory bowel diseases such as Crohn's 
disease (CD) and ulcerative colitis (UC)
[17]
, but also for diabetes mellitus (DM)
 [18]
. 
Novel therapeutic strategies have been proposed for the treatment of DM, such as the 
administration of growth factors, transplantation of pancreatic islands and infusion of 
SCs to replace dysfunctional beta-cells 
[19]
. Nevertheless, a possible side effect of SCs 
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Unravelling the cellular mechanisms governing stem cell behavior could lead to the 
development of new therapeutic approaches for tissue repair and other clinical 
applications. 
 
Figure 1. Regenerative medicine in biological reestablishment of tissue functions. Tissue 
engineering, gene and cell therapies, and stem cell research are some of the methodological 
approaches commonly used. 
1. Stem cells 
The origin of the term "stem cells" can be traced back to the late nineteenth century, in 
1868 precisely, when Ernst Haeckel, a major supporter of Darwin's theory of 
evolution, used the term "stem cells” to describe the unicellular ancestor organism 
from which all multi-cellular organisms presumably evolved 
[21][22]
. Stem cells are in 
fact undifferentiated primitive cells, with the unique ability to differentiate in the 
approximately 200 different cell types that form the body: neurons, skin cells, muscle 
cells, bone cells, liver cells, starting from the embryo and throughout the life span of 
each individual 
[23][24]
. Therefore, they can be described as cells whose fate has not yet 
been decided. Four criteria are used to define a stem cell. First of all, the cell must be 
able to undergo multiple and sequential cell divisions of self-maintenance, a 
prerequisite for supporting the cell population 
[25][26]
. Subsequently, from each cycle of 
replication by asymmetrical division, two daughter cells are generated, one of which 
may differentiate toward a particular cell line, while the other retains the features of 
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maintaining tissue homeostasis 
[27][28]
. The third criterion for defining stem cells deals 
with the ability to repopulate tissues when transplanted into a damaged recipient site, a 
property widely demonstrated for hematopoietic stem cells and more recently for 
progenitors of liver cells and nervous stem cells 
[29][8]
. A last criterion is that stem cells 
must contribute to a differentiated progeny in vivo even in the absence of tissue 
damages. They can undergo differentiation, giving rise to specialized cells through a 
process that depends on signals inside and outside the cell 
[30]
. Internal signals are 
controlled by specific genes, while external signals include physical contact with 
adjacent cells and specific molecules of their microenvironment, called “niche” [13][31]. 
The process of cellular specialization is genetically controlled by the cell nucleus and 
it is fundamental to allow the development of tissues 
[32]
. According to the level of 
specialization, stem cells can be classified as totipotent pluripotent, multipotent,
 
oligopotent and unipotent 
[33]–[35]
. In mammals, only the zygote, produced by the 
fusion of an egg with a spermatozoon, and the cells originating from the first divisions 
of the fertilized egg, the blastomeres, are totipotent and represent the founder cells of 
all the cells in the body 
[36]
. By successive divisions, embryonic stem cells originating 
from the zygote, are capable of generating all types of cells in the body, both in vivo 
and in vitro, but are uncapable of generating extra-embryonic tissues 
[37]
. Then, 
following the process of gastrulation, the three germinative leaves and differentiated 
cells are generated, including tissue-specific or somatic stem cells, which are 
responsible for the formation of the residing tissue 
[38]
. These cells have the function of 
maintaining the structural and functional integrity of the tissues through the 
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1.1 Embryonic stem cells 
Embryonic Stem Cells (ESCs) derive from the internal mass (Inner Cell Mass - ICM) 
of the blastocyst and can be easily isolated from the degradation of an embryo of 5-7 
days 
[41]
. The first lines of embryonic stem cells were isolated from mouse blastocyst 
at the beginning of the ‘80s, by Martin Evans and Gail Martin, followed by studies 
carried out in the late 1990s by James Thomson 
[42][43]
. They are cells that can not only 
be expanded indefinitely in culture while maintaining an undifferentiated state, but are 
also able to give rise to all adult cell types if injected into the blastocyst 
[44]
. Human 
embryonic stem lines were obtained from cells of the internal cellular mass that were 
surgically isolated, dissociated and grown on a layer of murine fibroblasts, which act 
as "feeder" 
[45][46]
. The term indicates a cell type capable to supply the nutrients or 
trophic factors necessary for the maintenance of cells in an undifferentiated state 
[47]
. 
ESCs can generate disorganized masses of mature cells of ectodermal, endodermal and 
mesodermal origin, called embryoid bodies (EB), and give rise to teratomas if injected 
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This ability, defined as pluripotency, make them extremely interesting as a possible 
therapeutic tool for any type of disease, but, at the same time, highlights their 
tumorigenic potential for uncontrolled differentiation 
[50]
. ESCs grown in vitro 
maintain self-renewal, telomerase activity, also retaining a stable diploid karyotype. 
The key genes implicated in the mechanisms of proliferation and self-maintenance are 
known as “Oct4-like” [51]. Oct4 is the main transcription factor of ESCs, expressed by 
the zygote during segmentation, being downregulated in the blastocyst and silenced in 
adult tissues 
[52]
. FoxD3 is another transcription factor that presents the same pattern of 
expression as Oct4 
[53]
. Other genes involved in self-renewal are Sox2 and Nanog. 
Nanog is a transcription factor belonging to the family of homeobox proteins and its 
expression seems instead limited to the cells of the internal mass and the primordial 
germ cells 
[54]
. In addition, there are also enzymes used as markers for human ESCs, 
such as alkaline phosphatase and telomerase 
[55]
. 
1.2 Adult stem cells 
The use of human embryonic stem cells arises ethical implications, as isolation of stem 
cells from blastocyst occurs only after destroying embryos. For these ethical concerns, 
somatic stem cells attracted the attention of scientists 
[56]
. Somatic or adult stem cells 
(Adult Stem Cells-ASCs) are capable to acquire a specific phenotype, according to the 
features of mature cells in their residing tissue. They show reduced levels of telomerase 
activity and a limited capability to differentiate, if compared to embryonic cells 
[57][58]
. 
Indeed, adult stem cells undergo an irreversible senescence process that involves a 
progressive differentiation toward the mature stage. For these reasons they are defined 
multipotent stem cells 
[34][59]
. 
It has been demonstrated that each tissue in the organism, can be a source of stem cells 
that could be used in autologous transplants, for the ability to differentiate into mature 
phenotypes 
[60]
. Bone marrow- derived stem cells (BM-MSCs), for example, can 
differentiate into hematopoietic line, glia, skeletal muscle or bone cells 
[61]
. Stem cells 
from dermis can differentiate into skeletal muscle, adipose tissue or cartilage. This 
ability to make different lineages has been defined as “plasticity” of adult stem cells [62]. 
The degree of plasticity suggests their possible use in the treatment of many diseases, 
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The first adult cells extensively characterized are hematopoietic stem cells (HSC). They 
support hematopoiesis, giving rise to all the  blood elements 
[63]
. 
They were isolated for the first time in mice, based on the antigenic characteristics of 
the surface: they express CD45, Thy1, c-kit and Sca-1 while not express lineage (Lin) 
and CD34 antigens 
[64]
. Even human HSCs do not express lineage and CD38 antigens, 
while they express CD45, c-kit and Thy1 and, unlike mouse antigens, are present in the 
CD34+ fraction of bone marrow, peripheral and cord blood 
[63]
. Recently, these criteria 
have been applied to identify adult stem cells from other sources, for example neural 




1.2.1 Mesenchymal stem cells 
 
Human adult mesenchymal stem cells (hMSCs) can contribute to the maintenance of 
normal homeostasis in all tissues through the replacement of the degenerated elements 
[66]
. Their definitive fate is regulated by specific signals, as biological molecules and 
biophysical factors 
[24]
. The presence of stem cells has been identified also at the level 
of the bone marrow stroma. The interest of researchers has thus focused no longer on 
the role of stroma as a support for hematopoiesis but on the potential of stem cells 
located there 
[67]
. Alexander Friedenstein and Maureen Owen were the first to use in 
vitro cultures and transplants in animal to characterize the cells that compose the bone 
marrow stroma 
[68]
. The cells isolated from the stroma are also called marrow stromal 
cells, mesenchymal stem cells (mesenchymal stem cell-MSC) or mesenchymal 
progenitor cells (MPC) 
[10]. They have a “fibroblast-like” morphology with very little 
cytoplasm, few mitochondria and a poorly developed Golgi apparatus, can be easily 
expanded in vitro and show differentiating potential towards various cell types: 
osteocytes, chondrocytes, adipocytes, astrocytes 
[69][70]
. The classical model of 
mesenchymal cell is derived from the stromal fraction of bone marrow. The isolation 
procedure involves the surgical removal of the portion of the matrix that is subsequently 




In vitro studies have shown that only some colonies derive from mesenchymal stem 
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differentiation potential. Hence characterizing and identifying the real mesenchymal 
stem cells actually represent a crucial issue 
[72]
. 
Since 1992 the existence of a precursor common to mesenchymal and hemopoietic 
progeny on fetal liver cells, characterized as CD34+, CD38-, HLA DR-, was 
hypothesized 
[73]
. In the spinal cord microenvironment, stromal cells produce the growth 
factors needed to promote the activation, proliferation and differentiation of responsive 
stem cells. Most of these cells are quiescent (G0 of cell cycle) in their niche and only a 
small fraction respond to paracrine messages, differentiating into CD34+ or 
mesenchymal stem cells 
[74][75]
. The CD34 marker, identified as a surface glycoprotein, 
belonging to the sialomucin family, and involved in the cell-cell and cell-matrix 
adhesion mechanisms, is expressed in hematopoietic progenitors and vascular 
endothelial cells but cannot be found on ex vivo expanded MSCs 
[76]
. In general, MSCs 
express numerous molecules important for cell adhesion and interaction with the 
microenvironment of the niche 
[13]
. They also express receptors for chemokine growth 
factors, integrins and markers shared with other cytotypes while they exhibit negative 
staining for typically hematopoietic markers such as CD45, expressed on myeloid cells, 
and CD14, receptor of bacterial lipopolysaccharide, found on monocytes 
[77][78]
. Three 
antigens have been identified whose simultaneous presence on MSCs, is commonly 
used for their characterization. First of all the antigen SH2, epitope of the endoglin 
CD105 or TGF beta-IIIR 
[79][80]
. It plays a key role in endothelial cell interactions and 
vessel development, mediates interactions between MSCs and hematopoietic cells in the 
marrow and could play a key role in chondrogenic differentiation by signal transduction 
[81]
. 
On the other hand, the monoclonal antibodies SH3 and SH4 recognize two different 
epitopes of CD73, an antigen present in many cell types and in particular in lymphoid 
tissue but not in hematopoietic precursors 
[82]
. In the spinal cord microenvironment, 
CD73 could mediate cell-cell interactions, representing a common element between 
stromal and lymphocyte development 
[83]
. Moreover, its expression can be related to the 
immunomodulatory activity of mesenchymal cells. Another interesting marker is the 
CD166 glycoprotein, also involved in osteogenic differentiation, although the precise 
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It is well known that MSCs bind monoclonal antibodies directed against the low affinity 
receptor for the nerve growth factor,  also known as CD271 
[86]
. This property has 
recently been successfully exploited to develop a method for cell selection by 
immunomagnetic sorting. 
Due to the low rate of availability and the invasive method to isolate BM-MSCs, new 
sources of mesenchymal stem cells have been recently evaluated: the human body hosts 
multipotent stem cells within several niches, including dental pulp, dermis, Wharton 
jelly of umbilical cord and adipose tissue 
[87][88]
. 
1.2.2 Adipose-derived stem cells 
Since the discovery in 2001 of a population of mesenchymal stem cells within its 
stromal compartment, human adipose tissue has been evaluated as an important suitable 
source for regenerative medicine 
[89]
. These cells, called adipose derived stem cells 
(ADSCs), have been shown to be available for adipose tissue generation, the creation of 
tissue banks, being also potentially cryopreserved for a long time 
[90]
. ADSCs are 
multipotent stem cells obtained from the vascular stromal fraction (SVF) of adipose 
tissue, consisting of CD34+/CD31- adipocyte precursors, CD34+/CD31+ endothelial 
cells and CD14+/CD31+ macrophages 
[91][92]
. According to several authors, ADSCs 
isolated from SVF can probably be considered “pericytes” or “perivascular progenitor 
cells” [93]. Like BM-MSCs, ADSCs generally show a fibroblast-like morphology and 
have properties and features equivalent to multipotent cells isolated from other tissues. 
The characterization of the ADSCs surface markers shows positivity towards the 
epitopes CD13, CD49a, CD49b, CD49d, CD90, CD105, STRO1, CD166, CD117 and 
CD29, CD44, CD49 and CD54, CD34, CD133, CD144 
[25][94]
. 
In vitro and in vivo studies have also shown a high degree of plasticity of these cells. 
ADSCs can be committed towards mesodermal derived tissues, as adipocytes, 
chondrocytes, osteoblasts, muscle cells, and towards non-mesodermal tissues, as 
angiogenic, hepatic, pancreatic, epithelial and neurogenic phenotypes 
[95][96]
.  
The adipose tissue can be collected from different sources through various methods of 
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The introduction of the modern liposuction technique at the end of the 1970’s, allowed 
the removal of subcutaneous adipose tissue through the use of cannula of variable 
diameter, through small incisions in the area of interest 
[98]
. 
This technique has the advantage of obtaining large amounts of adipose tissue with 
minimally invasive procedure, simplifying isolation and making it less traumatic 
[99]
. 
In the following years, several improvements were made in the instrumentation, 
techniques and devices used. The isolation of the cellular component residing in the 
adipose tissue involves mechanical trituration followed by enzymatic digestion 
[100]
. The 
recovery of ADSCs is higher than that of other classical adult sources such as bone 
marrow: the ADSCs constitute 2% of the lipoaspirate cells, while the MSCs in the 
marrow represent less than 0.1% 
[101]
. An innovative technique to minimize the 
manipulation of any cellular product, in order to maintain the native characteristics of 
the tissue, was developed by Tremolada and collaborators. It is based on non-enzymatic 
processing of lipoaspirates, called Lipogems®, to obtain a minimally manipulated 
preparation containing vital ADSCs, with elimination of the oil and blood residues 
[102][103]
. In vitro tests revealed the differentiating and immunomodulatory capability of 
these cells, representing an excellent candidate in regenerative medicine approaches. 
Moreover, unlike other lipoaspirates, this product can be frozen without losing the vital 




2. Adipose Tissue 
 
Adipose tissue (AT) is a connective tissue responsible for different physiological 
functions 
[105]
. It is composed of adipocytes, surrounded by a stroma of connective 
fibers, intercellular matrix, fibroblasts, immune system cells and blood vessels 
[106]
. 
For many decades, the adipose tissue has been viewed as a passive organ dedicated to 
lipids storage during excessive caloric intake, capable of releasing energy when 
needed by other organs 
[107][108]
.  
It represents an important energy reserve for the body, prevents the dispersion of 
internal heat, protects and supports the internal organs 
[109]
. Adipose tissue exerts also 
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Adiponectin is involved in regulation of glucose and lipid metabolism and energy 
homeostasis, while resistin is responsible for insulin resistance and inhibits the activity 
of AMPK (AMP-activated protein kinase) in liver and skeletal muscle 
[111][112]
. On the 




The distribution of adipose tissue in human body depends on age and gender 
differences. In men, fat is mainly stored around the waist, while fat accumulation in 
woman is around the hips 
[114][115]
. Moreover, with aging, changes in body composition 
are associated not only with modifications in total adiposity and body weight, but also 
with increase in bone marrow fat content, leading to lower bone mineral density and 
the risk of elderly fractures 
[116]
. Adipose tissue can be classified in subcutaneous 
adipose tissue (SCAT), with mechanical and protective functions 
[117]
, and visceral 
adipose tissue (VAT), a hormonally active component of total body fat presents in the 
abdominal cavity 
[118]
. Accumulation of adipose tissue is also formed between muscles 
and in the connective sepia that separate the various bundles. The subcutaneous 
adipose tissue affects the entire body surface and above all the deep layers of skin 
[119]
. 
The 50% of the fat is located in the subcutaneous panniculus, where it performs both 
an insulating and a mechanical function; 45% in the abdominal cavity, forming the 
visceral adipose tissue, and, finally, for 5% in the muscle tissue, where supports 
muscular activity 
[120]
. SCAT and VAT show difference in their structures and in 
endocrine system regulation. In mammals, VAT contains greater numbers of large 
APCs than SCAT, which generally contains small adipocytes but a higher lipolytic 
activity 
[110][121]
. In addition, non-adipocyte resident cell population secrete higher 
levels of proinflammatory cytokines in VAT then in SCAT, responsible for increased 
risk of developing insulin resistance and metabolic syndromes 
[122]
. Adipocytes are 
responsible of storing triglycerides during calories intake and to mobilize these 
reserves in the form of fatty acids, according to the tissue needs 
[123]
. Mature 
adipocytes retain a large number of enzymes and regulatory proteins crucial for 
lipolysis and lipogenesis 
[124]
. 
Some of these molecules, such as adipokines, are secreted in the blood, and are able to 
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pancreas, liver, skeletal muscle tissue, kidneys, endothelium and immune system 
[125][126]
. 
Therefore, adipose tissue plays a key role in homeostatic regulation of the energy 
balance, insulin sensitivity and vascular-endothelial function 
[109][110]
. Alterations in 
distribution of adipose tissue and its endocrine function are related to insulin 




The molecular mechanisms involved in this kind of mutations are not fully known yet. 
It is believed that these alterations are mainly related to a dysregulation in VAT 





Figure 3. Structure of adipose tissue. Mature adipocytes are the main population composing 
adipose tissue. Images are acquired by optical microscope. Scale bar=100µm. 
 
2.1 Types of adipose Tissue 
 
In mammals, the fat is organized as white (WAT) and brown (BAT) adipose tissue, 
having typical structures and functions 
[130]
. WAT stores energy as triacylglycerol 
(TAG), whereas BAT dissipates energy as heat by acid fatty metabolism 
[131][132]
. 
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2.1.1 Beige adipose tissue 
 
Beige adipose tissue, also called “brite”, derives from the differentiation of precursor 
cells in mature adipocytes or from the transformation or trans-differentiation of pre-
existing white adipocytes 
[134]
. This kind of cells, classified as beige/brite or brown-




WAT, following certain stimuli, can transdifferentiate from a WAT phenotype toward 
a BAT-like one, modifying its morphology, gene expression and mitochondrial 
activity. At the beginning, they exhibit large lipid drops and the absence of 
UCP1
[137][138]
. When they receive thermogenic stimuli, the adipocytes changes their 
morphology to brown like features: multilocular lipid drops, with a low expression of 
UCP1 
[139][140]
. The process of WAT transforming into beige is called “browning”[141]. 
This transformation may depend on various stimuli, including hormonal signals as 
catecholamines. These are hormones released in stressogenic situations and may have 
relevant therapeutic applications for obesity and obesity-related syndromes in humans 
[142]
. The factors able to induce the darkening of the WAT are classified in the class of 
activators of the SNS 
[143]
. This mechanism leads to the activation of lipolytic 
phenomena and fatty acid oxidation, and is also associated with over-expression of 
genes involved in mitochondrial function and thermogenesis typical of brown 
adipocytes 
[144]
. Among the activators of the sympathetic nervous system, we 
distinguish the β-adrenergic agonists and the endogenous signal neuropeptides. 
Transcription factors as peroxisome proliferator-activated receptor-γ (PPARγ), 
CCAAT/enhancer-binding protein beta (C/EBPβ), and FOXC2, growth factors, as 
Bone morphogenetic protein 7 (BMP7), FGF21, BDNF, and BMP8B, enzymes and 
proteins associated with lipid drops, as perilipin, are also included 
[145]–[147]
. 
Understanding the cellular mechanisms controlling the plasticity of WAT-BAT could 
lead to the design of future treatments and drugs for type 2 diabetes and obesity, also 
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2.1.2 White adipose tissue 
 
The WAT, also called unilocular tissue, consists of cells in close contact with each 
other, with a poor extracellular matrix 
[149]
. 
The adipocytes are very huge and can reach 150-200 µm in diameter. The adipocytes 
are arranged to form aggregates, between which numerous blood vessels are placed 
[150]
. 
The lipid drop is one, unilocular, which lodges almost the entire intracellular space, 
while the cytoplasm is reduced and located on the periphery of the cell. This tissue is 
constantly exposed to mechanical stresses 
[151][152]
. The principal functions of WAT are 
the storage of lipids during fasting and the release of fatty acids through β-oxidation 
process, providing adenosine triphosphate (ATP) for cellular biological processes 
[153]
. 
The white adipose tissue is also known as an important secretory organ, producing 
cholesterol, retinol, steroid hormones, prostaglandins and adipokines 
[154][155]
. 
Alterations or inadequate release of these molecules, can lead to the onset of diseases, 
as obesity, insulin resistance, increased risk of metabolic syndrome, cardiovascular 
diseases and other more 
[156][157]
. WAT can be distinguished in subcutaneous, under the 
skin, or omental, that can be localized inside the abdomen (gonadal, mesenteric, 




2.1.3 Brown adipose tissue  
 
The brown adipose tissue, also called multilocular, consists of adipocytes widely 
distributed and significantly smaller than the WAT. However, adipocytes form 
aggregates with a glandular-like appearance, with a real endocrine function 
[159][136]
. 
BAT is a highly vascularized and innervated tissue, and brown adipocytes possess 
multilocular lipid droplets and a high number of mitochondria, whose cytochromes are 




In fact, a special transmembrane channel protein called thermogenin is placed in the 
internal membrane of the mitochondria, which allows the passage of protons to the 
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This tissue is responsible for the metabolism of fatty acid, thanks to the presence of 
mitochondria uncoupling protein 1 (UCP1). Activation of UCP1 stimulates the uptake 
of lipids and glucose from circulation to support thermogenesis 
[131][164]
. 
The thermogenesis of BAT is physiologically stimulated by noradrenaline released by 
the nerve fibers of the sympathetic system (SNS) 
[165]
. 
The transduction of the thermogenesis signal occurs mainly through the β-adrenergic 
receptors present on the membrane of brown adipocytes 
[166]
. The activation of 
adenylate cyclase (AC, adenylyl cyclase) leads to increased levels of cytosolic cyclic 
adenosine monophosphate (cAMP). Increased cAMP induces hydrolysis of 
triglyceride reserves through the activation of protein kinase A (PKA) 
[167][168]
. 
Through this process, the fatty acids are released and act as a substrate for 
mitochondrial oxidation and, at the same time, activate the UCP1 
[169]
. BAT is typical 
of rodents and hibernating animals. In humans it provides thermoregulation in the first 
years of life. The amount of BAT tends to decrease with age and persists in adulthood 




2.2 Features of cells in adipose tissue 
 
Adipose tissue is a heterogeneous cell population, including mature adipocytes, 
endothelial cells, macrophages, pericytes, and pre-adipocytes or adipose-derived 
stromal/stem cell 
[172]
. Mature adipocytes originate from precursor cells differentiation 
placed in the connective tissue and capable to differentiate into adipocytes, 
chondrocytes, osteoblasts, and myocytes 
[10]
. These precursor cells are called lipoblast 
or preadipocyte or adipoblasts 
[173]
. During development, these cells progressively 
accumulate lipid drops in their cytoplasm, becoming globular, with a very reduced 
cytoplasm that forms a ring around a single large vacuole rich in lipids 
[174][175]
. 
WAT formation is the results of increasing adipocyte size and number. The potential 
to produce new fat cells from lipoblast continues throughout the lifespan 
[176]
. In the 
course of differentiation, a series of chronological changes in the expression of 
numerous genes occur. This event is represented by the appearance of mRNAs and 
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Among the various transcription factors involved in adipocyte differentiation, 
CCAAT/reinforcing binding protein (C/EBP-) and peroxisome proliferator-activated 
receptor (PPAR- γ) are involved in the activation of adipo-specific genes and in the 
cell-cycle arrest, required for adipocyte differentiation 
[178][179]
. 
C/EBP-is expressed slightly before the first phases of gene transcription as compared 
to PPAR- γ. C/EBP transcription factor interact also with Co-activator-3 steroid 
receptor (SRC-3) in regulating PPAR2 expression and white adipocytes formation 
[180][181]
. Although the expression of C/EBP-α and PPAR-γ increases dramatically 
during adipocyte differentiation, the low level of these factors expressed as 
preadipocytes may be enough to mediate the growth arrest preceding differentiation 
[182]
. Lipoprotein lipase (LPL) is secreted by mature adipocytes, but also by other cell 
types such as heart muscle cells and macrophages, and is important in controlling lipid 
accumulation and in catalyzing the hydrolysis of triglycerides 
[183]
. Preadipocyte 
factor-1 (Pref-1) also participates in the maintenance of the pre-adipogenic phenotype. 
During the last phase of differentiation, cultured adipocytes significantly increase 
lipogenesis and become insulin-sensitive 
[182][184]
. Adipocytes also synthesize other 
specific adipose tissue products not directly related to lipid metabolism. These include 
aP2, an adipocyte-specific fatty acid binding protein found in adipose tissue and plays 
an important role in intracellular metabolism and fatty acid transport 
[185]
. Acyl-
coenzyme A (CoA)-binding protein (ACBP) is also significantly induced during 







2.3 Understanding adipocytes features a lesson from the clinic: obesity and 
obesity-related disorders 
 
Obesity is a multifactorial worldwide disease in adults, as well as among children and 
adolescents, associated to a great risk of morbidity and mortality due to an abnormal 
and uncontrolled fat accumulation in adipose tissue 
[187][188]
. Obesity has become a 
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diagnosis and treatment. Premature mortality, disability, loss of productivity and 
absenteeism are only a few of the consequences related to it 
[189]–[191]
.  
Moreover, a large part of the health expenditure for treatment of obesity comes from 
public insurance. The excess of fat depots is measured according to Body Mass Index 
(BMI) determination, a parameter derived from the weight in kilograms divided by the 
square of the height in meters (kg/m2) of the individual 
[192]
. Based on the data from 
the Global BMI Mortality Collaboration, a BMI of 20.0-25.0 kg/m2 is associated with 
the lowest mortality rate. According to World Health Organization (WHO) a BMI 
greater or equal to 30 Kg/m2 is consistent with obesity and a BMI between 25 and 30 
Kg/m2 identifies overweight 
[193][194]
. Obesity is classified according to BMI in:  
 Normal weight  18-25 
 Overweight  30-35 
 1st degree obesity 30-35 
 2nd degree obesity 35-40 
 Severe obesity             40-50 
 Super obesity  >50 
The distribution of adipose tissue in the body has important implications for health 
[195]
. Obesity is the result of the intake of excessive calories needed for body activity. 
In mammals, a complex set of hormones and nerve signals acts to keep energy and 
nutrient consumption balanced 
[196]
.  
In maintaining the body's homeostasis, the signal produced in the adipose tissue is able 
to influence the brain centers that control eating behavior and metabolic activity 
[197]
. 
Adipokines and in particular leptin secreted by adipose tissue, provide the information 
on the availability of energy tissue reserves, stimulating the production of the anorexic 
hormone that suppresses appetite 
[198]
. Obesity is often associated with metabolic 
syndrome and onset of type II diabetes, followed by cardiovascular disease, kidney 
failure, blindness, difficulty in healing wounds and, first of all, development of insulin 
resistance 
[199][200]
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increase in adipose tissue, in particular the omental tissue, the number of 
macrophages, responsible for the elimination of damaged adipocytes 
[201]
 also grows. 
Macrophages in obese subjects control the production of most cytokines, followed by 
a drastic increase in insulin production 
[202]
. Cytokine production, together with the 
reduced sensitivity to insulin is the main cause of the complications associated with 
obesity: cardiovascular diseases (CVD), hypertension and other more, leading in the 
most serious cases to premature death 
[127][203]
. Not all obese patients show the 
symptoms of obesity-related disorders. This fraction of patients has a regular insulin 
sensitivity and reduced amount of visceral fat compared to obese patients with 
metabolic syndrome 
[204]
. The metabolic syndrome is associated with dyslipidemia, 
hyperglycemia, hypertension, doubling the risk of coronary heart and cerebrovascular 
disease 
[205]
. Therefore, obesity depends on body composition rather than on body 
weight and in particular on the number of adipocytes. The treatment of obesity 
requires a prolonged and determined effort 
[206]
. Actually, interest of research is aimed 
at finding methods leading to a decrease in weight by eliminating adipose tissue 
without affecting the non-lipidic mass 
[207][208]
. Understanding the mechanisms of 
adipocytes differentiation could pave the way for future therapeutic application and 
development of new drugs and methodologies to counteract severe obesity in patients 
[209]
. 
3. Stem cell plasticity 
MSCs are able to acquire different phenotypes replacing injured elements under 
external signals from their microenvironment, acting to maintain tissue homeostasis 
[210].  
In the regeneration processes, stem cells residing in tissues not affected by the damage 
may also contribute to the function recovery after injury 
[211]
. The plasticity of stem 
cells is the ability of adult tissue stem cells to acquire a new identity. The term 
plasticity also indicates the potential of stem cells to differentiate into adult cells 
phenotypically different from those of their original tissues 
[212][62][213]
. In response to 
different types of signals, stem cells are able to rearrange their membrane and 
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represent the ability to redistribute cellular organelles and proteins for cell division and 
migration 
[214][215]
. Cell viability, cell proliferation and tissues homeostasis are 
regulated by a perfect and controlled balance between symmetrical and asymmetrical 
division of MSCs 
[27]
. The asymmetric division leads to the formation of two different 
daughter cells. One with self-renewal properties, like the mother cell, and the other 
one that differentiate toward a specific cell type and has a reduced regenerative 
potential 
[28][216]
. Alterations in this system are related to the loss of tissue function, as 
occurs in aging 
[217]
, when stem cells lose their regenerative potential by dividing 




4. Epigenetic of self-renewal and differentiation 
Stem cell differentiation is a complex process controlled by signaling pathways and 
molecular mechanisms that influence the expression of the main stem markers 
Transcription Factor 4 (Oct-4), sex determination region Y-box 2 (Sox-2) and 
Homeobox Nanog protein (Nanog) 
[219][220]
. These transcription factors are essential in 
maintaining MSC pluripotency and are also involved in adult somatic cell 
reprogramming. If these factors are downregulated, cells immediately start the 
differentiation process 
[221][221]
. These transcription factors are also able to suppress a 
group of genes needed by the embryo for development. If repressed, these set of genes 
leads to production of additional transcription factors responsible for the activation of 
genes needed for differentiation 
[222]
. When the embryo begins to grow, Oct4, Sox2 and 
Nanog are inactivated and the ESCs lose their pluripotency. These transcription factors 
could thus be considered positive stem switchers: they regulate the expression of other 
genes by direct interaction with chromatin or through the presence of other factors, 
changing the conformation and making certain regions accessible or not for 
transcription 
[223][224]
. The expression of pluripotency genes influence cell cycle and 




In vitro studies on MSCs show that an over-expression of Oct4 and Sox2 results in the 
promotion of proliferation, with an increase in the duration of the S phase of the cell 
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. On the other hand, the over-expression of Nanog has been 
shown to slow down adipogenesis in MSCs 
[228]
. Epigenetics refers to the range of 
hereditary changes in the structure of chromatin that can influence gene expression and 
represents the molecular reaction to all environmental changes 
[229]
. 
These chromatin modifications, involving miRNA, DNA methylation and chromatin 
remodeling, are orchestrated by different types of enzymes, such as DNA 
methyltransferases (DNMTs), histone deacetylases (HDACs) and histone 
acetyltransferases (HATs) in a still unclear fashion 
[230][231]
. Epigenetic mechanisms are 
able to guide the MSCs behavior from the undifferentiated to the differentiated state. 
Environmental and developmental stimuli influence chromatin structure and the 
activation of a specific transcription program, playing a central role in maintaining MSC 
regenerative potential 
[232][233]
. DNA methylation plays a key role in reprogramming 
somatic cells, through repression of differentiating genes and regulation of the MSC 
undifferentiated state 
[234]
. Additionally, microRNAs (miRNAs), small non-coding 
RNAs, have been discovered as regulators of cell pluripotency and reprogramming, 
suggesting their possible therapeutic application of various disorders, including 
myocardial infarction, neurodegenerative and muscle diseases 
[235]–[237]
. Nevertheless, 
further studies and continuous innovations are needed in the attempt to develop novel 
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Figure 4. Epigenetic modulators exert a role in modulating stem cell fate, finely tuning 




5. Orchestrating stem cell identity 
Since the discovery of stromal cells from adipose tissue, several researchers have been 
interested in the use of molecules in the attempt to modulate stem cell commitment 
[233][238]
. These natural and synthetic molecules exert their action via epigenetic 
modulations of a specific molecular differentiation program and gene expression of 
lineage-specific markers 
[239][240]
. ADSCs cultured in the presence of calcium, or 
ascorbic acid, β-glycerol phosphate and dexamethasone in the growth medium, are 
capable to differentiate into osteoblasts, inducing an increase in the levels of 
expression of involved transcription factors 
[241][242]
. Colorimetric tests (e.g. Alizarin 
Red) and gene expression analysis of the main osteogenic genes, highlight the 
accumulation of intracellular calcium deposits and reduced expression of stemness 
genes 
[243]
. Retinoic acid (RA) promotes neural differentiation in mouse embryonic 
cells 
[244]
, or cardiac differentiation where used in combination with butyric acid and 
hyaluronic acid esters (HBR), increasing the transcription of cardiogenic genes and 
various growth factors such as VEGF (Vascular Endothelial Growth Factor) and HGF 
(Hepatocyte Growth Factor) 
[245]–[247]
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has been successfully used to induce an osteogenic phenotype in dental pulp stem cells 
(DPSCs) 
[248]
. Some authors found that the activin A, bone morphogenetic protein 4 
(BMP4), VEGF or Dickkopf-related protein 1 (DKK1), can optimize cardiac 
development in human stem cell lines and mice 
[249][250]
. Different combination of 
activin A, nicotinamide and resveratrol are able to induce mouse ADSCs 
differentiation into Insulin-Producing Cells 
[251][252]
. The addition of dexamethasone, 
HGF, fibroblast growth factor 4 (FGF4) and other growth factors in the culturing 
medium induce ADSCs differentiation towards functional hepatocyte-like cells 
[253][254]
. These findings highlight the chance to apply in vitro modulation of stem cells 
potential for future in vivo applications with a great impact in regenerative medicine 
[255], [256]
. 
5.1 Focus on: Melatonin 
A wide range of natural molecules and compounds, known as nutraceuticals or 
functional foods, are widely used for their therapeutic or preventive effects 
[257]
. 
Melatonin (N-Acetyl-5-methoxytryptamine), synthetized from serotonin by pineal gland 
during the night, is a neurohormone involved in regulating circadian rhythm and 
reproduction, and in a number of other pleiotropic effects 
[258][259]
. Melatonin can exert 
many other functions on mitochondrial activity and on the immune cell production, as 
well as anti-apoptotic properties, improving the outcome of stem cell transplantation 
[260][261]
. In addition, melatonin also exhibits various effects on stem cells, controlling 
cell viability and differentiation. It is a molecule greatly preserved with physiological 
and pathophysiological functions, and whose synthesis decays with aging 
[262][263]
. 
Melatonin is able to induce neural differentiation of stem cells in transplanted mice 
reducing the production of reactive oxygen species 
[264]
. Moreover, melatonin can 
influence the differentiation of MSCs towards osteogenic, chondrogenic, adipogenic 
and myogenic lineages 
[265]. These processes involve the activation of Wnt/β-catenin 
pathway, MAPKs and TGF-β signaling, and the recruitment of AMPK-activated protein 
kinase (AMPK), and the protein Forkhead box O3 (FOXO3) 
[266][267]
. AMPK activation 
is also involved in the regulation of the expression of the peroxisome proliferator-
activated receptor gamma γ (PPARγ), the main adipogenic orchestrator gene and 
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These physiological effects exerted by melatonin, are mediated by the interaction with 
specific G protein-associated receptors, including MT1 and 2 
[269][270]
 and with 
epigenetic modulators as HDACs or Sirtuins, a class of proteins involved in a wide 
range of cellular processes 
[271][272]
. In particular, SIRT 1, 3 5, are mostly involved in 
metabolic controls, while SIRT2 and SIRT6, are mainly related to aging processes. The 
ability of melatonin to decrease body weight and inflammation, promoting adipocyte 
pyroptosis 
[273]
 and protecting tissue against mitochondrial dysfunction, suggest an 




5.2 Vitamin D 
Vitamin D is a fat-soluble vitamin with numerous biological properties, capable of 
influencing the physiology of the body system through the epigenetic regulation of 
over 200 genes 
[276]
. It is involved in the maintenance of calcium and phosphate 
homeostasis and in the processes of bone mineralization, and its deficiency determines 
the onset of various diseases 
[277]
. It is synthetized from a liposoluble prohormone that 
is exposed to a series of hydroxylation reactions in the skin, liver and kidney 
[278]
, 
starting from a cholesterol precursor, 7-dehydrocortisol, becoming vitamin D2 (25-
hydroxyvitamin D3) or ergocalciferol, and vitamin D3 (1,25-dihydroxy vitamin D3) or 
cholecalciferol, its biologically active form 
[279][280]
. Once synthetized, it is released 
into the blood where, thought vitamin D-binding protein (DBP), it can be absorbed by 
adipose tissue or transported to the liver for subsequent activation 
[281][278][282]
. The 
enzymes responsible for both vitamin D activation and inactivation are part of the 
cytochrome P450 monooxygenase (CYP) family 
[283][284]
. In humans, the main CYPs 
associated with vitamin D are CYP24A1, CYP27A1, CYP27B1 and CYP2R1 
[285]
. 
CYP27A1, CYP2R1, CYP3A4 and CYP2J3 are mainly located in the liver and are 
involved in the first phase of pre-vitamin conversion at the c-25 site into 25-hydroxy-
vitamin D3 or calcitriol 
[286]
. CYP27B1 and CYP24A1 are mainly located in the renal 
tubules and complete the activation pathway with hydroxylation at the c-1, producing 
1,25-dihydroxyvitamin D3 or biologically active cholecalciferol 
[287]
. In order to 
perform its function, the 1,25-(OH)2D3 bind to a nuclear receptor, the vitamin D 
receptor (VDR) 
[277]
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and acts as a transcription factor induced by ligand 
[288][289]
. The binding between 
vitamin D and the VDR induces conformational changes in the activation domain, 
allowing the formation of the transcriptional complex associated with the retinoid 
receptor X (RXR) 
[290]
. The heterodimer formed binds to the specific DNA sites called 
VDRE (Vitamin D response elements), modulating the enzymes responsible for the 
chromatin modification 
[280]
. 1,25-(OH)2D3 is able to influence chromatin remodeling 
by modulating HDACs and DNA methylation. VDR is expressed in adipocytes and 
regulates adipogenic gene expression and apoptosis, and is involved in the control of 
calcium homeostasis and osteogenic-associated genes (osteocalcin, osteopontin, 
calbindin, calcium channels) 
[291][292]
. Many genes activated by vitamin D are involved 
in various other systems, such as the regulation of proliferation and cell differentiation, 
and in oxidative stress, inflammation and immune response 
[293][294]
.  Recent studies 
highlighted the role of 1,25(OH)2D3 in influencing the gene expression of key 
molecules involved in adipogenesis, fat oxidation and lipolysis through the activation 
of the nicotinamide-dependent adenine dinucleotide (NAD)-signaling pathway 
[182][295][296]
. Vitamin D deficiency leads to altered bone development, such as rickets in 
children and, in adults, to a variety of health problems as osteoporosis, muscle 
weakness, cardiovascular disease, metabolic syndrome, multiple sclerosis, mental 
defects, a variety of cancer diseases and many other disorders 
[297]–[299]
. Vitamin D and 
VDR deficiency has also recently been proposed as a cause of obesity 
[300][301]
. 
Deficiencies are commonly caused by an insufficient intake or imbalance of enzymes 
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Figure 5. Vitamin D metabolism involving P450 enzymes 
[303]. 
 
5.3 Natural extracts from plants  
Nutraceuticals are applied in regenerative medicine for their potential to modulate 
physiological processes and cure a variety of disorders 
[304][305]
. Medicinal plants are 
known for their antiseptic, antibacterial and anti-inflammatory properties 
[306]
. They 
also have antioxidant activities and stimulate tissue regeneration counteracting acute 
inflammation 
[307]–[309]
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Myrtus communis L. belongs to this class of plants, known for the amount of bioactive 
polyphenols, mainly anthocyanins, in its berries and seeds 
[310]
. Commonly used for 
the production of liqueur in the food industry 
[311]
, it represents an important resource 
that can be used as a food supplement or extracts with antioxidant and anti-
inflammatory activity 
[312]
. Chronic inflammation leads to excessive secretion of 
proinflammatory cytokines (TNF-α and IL-6) involved in the onset of several diseases 
[313][314]
. The production of reactive oxygen species (ROS) contribute to worsening the 
fall of the inflammatory state, increasing the release of cytokines, aging, cancer, 
diabetes, and atherosclerosis 
[315][316]
. Polyphenols, as anthocyanins, gallic acid 
derivatives and flavonoids, counteract the release of toxic molecules and stimulate 
physiological defenses 
[317]
. The class III NAD-dependent histone deacetylase sirtuin-1 
(SIRT1) regulates various physiological processes and is involved in metabolism, 
stress response and aging 
[318]
. Several studies have shown that downregulation of 
SIRT1 promotes inflammatory cytokine secretion, whereas when upregulates protects 
from premature senescence and oxidative stress 
[319][320]
. In addition, phytochemicals 
are involved in the heat shock-induced response as a mechanism of self-defense 
[321]
. 
Heat Shock Proteins (HSPs) are responsible for protein homeostasis and play an 
important role in aging, also protecting cells from oxidative stress damages 
[322]
. 
Limited ROS production, together with modulation of TNF-α release, play a critical 
role in the enrolment of stem cells at injured sites, indorsing cell migration and tissue 
regeneration 
[323][324]
. For these reasons, natural extracts can be applied in the attempt 
to drive cell proliferation and activate natural defenses through epigenetic regulations 
and post-transcriptional modifications 
[325][326]
. 
6. Translation to clinical applications 
Adult stem cells have attracted the attention in the field of regenerative medicine for 
their easily in vitro expansion and the ability to differentiate towards different 
phenotypes, overcoming ethical issues related to the use of ESCs 
[327]
. MSCs are 
currently used in gene therapy and in the treatment of serious diseases, sometimes 
representing the only alternative to conventional treatments to improve the quality of 
life of the patients 
[328][329]
. Transplant of MSCs is currently the most frequently used 
cell therapy in hematological diseases 
[330]




Exploring stem cell fate from adipose tissue: novel approaches to modulate stem cell signatures. 
Dottorato in Scienze Biomediche, Curriculum Fisiopatologia Medica, Università degli Studi di 
Sassari. 
 








studies for neurological amyotrophic lateral sclerosis (ALS) 
[331][332]
. ALS is 
characterized by progressive spinal cord motor neurons degeneration, involving 
toxicity and inflammatory processes associated with resident cell populations 
[333]
. 
Currently drugs that suppress oxidative stress, can be used in the attempt to maintain 
motor neuron function 
[334]
. Autologous MSC transplantation represent an alternative 
to conventional therapy. MSCs are used as therapeutic tools in stem cell transplants for 
their immunomodulatory properties, secretion of growth factors and regeneration of 
damaged tissues, especially in patients refractory to conventional therapies 
[335][336]
. 
Autologous transplants are applied in leukemias, lymphomas, multiple myeloma and 
other hematological neoplasms 
[337]
. The discovery of a population of ADSCs residents 
in stromal fraction of adipose tissue, has paved the way for several possible 
applications of lipoaspirate in the field of regenerative medicine 
[338]
. Stem cells 
derived from adipose tissue have been shown to improve wound healing, ulcers and 
skin defects 
[339]
; they can be used for the regenerative treatment of large head and face 
defects due to trauma or simply age, or used for joint reconstruction in arthritis 
[340]
. 
The use of adipose tissue is very promising in breast reconstruction in patients who 
have undergone mastectomy for breast cancer and subsequent radiotherapy 
[341]
. After 
the infiltration of adipose tissue, a marked improvement was observed due to the 
deposition of new collagen, skin hypervascularization and dermis hyperplasia in the 
case of face burns of  2 and 3 degrees 
[342][343]
. Co-transplantation could also play an 
important role in preventing or contrasting the Graft-versus-Host disease (GvHD), one 
of the most frequent clinical complications of rejecting allogeneic bone marrow 
transplants 
[344][345]
. For these reasons, adipose tissue is considered an ideal source of 
stem cells that can be used for tissue generation and reconstruction and, above all, for 
autologous transplants 
[346]
. For acute diseases such as heart attack or immunologically 
based diseases as diabetes, allogenic therapy may be necessary unless cells can be 
obtained in large quantities from the patients 
[347]
. Nowadays, several clinical trials 
with MSCs are ongoing, being successful in the treatment of imperfect osteogenesis, 
in improving the rooting of transplanted HSCs and in the control of autoimmune 
diseases (multiple sclerosis) and the rejection of transplants, in the repair of metabolic 
diseases (juvenile diabetes), cardiovascular system (heart attack, stroke) and the 
nervous system, as Alzheimer and Parkinson 
[347]–[349]
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govern these processes, should lead to an improvement in the methods for stem cell 
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AIM OF RESEARCH 
The stromal fraction of adipose tissue is an important source of stem cells exploitable 
in regenerative medicine. MSCs residing in adipose tissue play an important role in the 
maintenance of cellular and tissue homeostasis, replacing dead or non-functioning 
cells. Fat tissue seems to play a central role in inducing inflammation, as excessive 
nutrition leads to changes in its cellular composition and to the production of pro-
inflammatory cytokines. Hence, inflammation occurring in the injured tissue acts by 
recruiting resident MSCs. Abdominal obesity is associated with a state of chronic 
inflammation, which leads to insulin resistance and metabolic disorders. 
Understanding the cellular mechanisms involved in the activation and differentiation 
of the adipose resident stem cells, could help in identifying innovative and preventive 
tools to counteract obesity and the related diseases. The aim of this project was to 
evaluate cell behavior in the presence of conditioned media, drugs or natural 
molecules, in the attempt to counteract the molecular mechanisms involved in 
inflammatory-associated adipogenesis. Within this context, we aimed at modulating 
the epigenetic mechanisms involved in stem cell differentiation and cellular behavior, 
reducing both the production of pro-inflammatory cytokines and the inappropriate 
activation of adult stem cells in stressful conditions. The findings obtained here could 
open up novel strategies for future therapeutic approaches in epigenetic controlling 
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MATERIAL AND METHODS 
7.1 Adipose-derived stem cell isolation 
Adipose-derived Stem cells (ADSCs) were isolated from subcutaneous and omental 
adipose tissue harvested during surgery processes for different reasons, from human 
adult female and male patients (n = 12, age = 45 ± 15 years, BMI: 22 ± 3 kg/m2). All 
the patients participating at the study, approved by the Ethics Committee Review 
Boards for Human Studies in Sassari (n◦ ETIC 240I/CE 26 July 2016, Ethical 
committee, ASL Sassari), signed a written informed consent. Cell isolation procedures 
were performed by mechanical and enzymatic digestion of fat tissue, which was washed 
repeatedly with sterile Dulbecco’s phosphate buffered saline (DPBS) (Euroclone, 
Milano, Italy) containing 200 U/mL penicillin and 0.1 mg/mL streptomycin (Euroclone, 
Milano, Italy), to remove the blood cells. Subsequently, fat sample was mechanically 
reduced to small fragments by sterile scalpels and then enzymatically digested for 1 
hour at 37°C in a solution of 0,1% Collagenase Type I (Gibco Life Technologies, Grand 
Island, NY, USA). The enzyme activity was neutralized with 10% of fetal bovine serum 
(FBS) (Life Technologies, Grand Island, NY, USA) and the fat digestion solution was 
filtered with 70 μm cell strainer (Euroclone, Milano, Italy) and centrifuged at 600× g for 
10 min, to separate the two distinct cell fractions of mature adipocytes, that were 
removed, and the stromal vascular fraction (SVF) that includes adipose-derived stem 
cells. The SVF in fact, is composed of preadipocytes, endothelial cells, pericytes, 
fibroblasts, adipose-derived stem cells (ADSCs) and hematopoietic stem cells. After 
collagenase digestion, mature adipocytes with a high fat content are separated as a 
floating layer. The adipocytes were transferred into a 12 cm2 culturing flasks filled with 
basic Dulbecco's modified Eagle's Medium (DMEM) (Life Technologies Grand Island, 
NY, USA) supplemented with 20% fetal bovine serum (FBS) (Life Technologies, 
Grand Island, NY, USA), 200mM L-glutamine (Euroclone, Italy), and 200 U/mL 
penicillin—0.1 mg/mL streptomycin (Euroclone, Milano, Italy). The flasks were placed 
upside-down in incubator at 37°C with 5% CO2. Once attached, the adipocytes were 
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All cells remaining after the removal of mature adipocytes constitute the SVF. The 
pellet of SVF was resuspended into a basic medium, plated in 12 cm2 culturing flasks 
and transferred in incubator at 37°C and 5% CO2. After 48 h of incubation, the cultures 
were washed with DPBS and kept in the fresh medium. The culture medium was 
changed every 3 days. When the cells reached 80–90% confluence, they were harvested 
using 0.25% Trypsin EDTA (Euroclone, Milano, Italy), counted and passed into new 
flasks.  
 
7.2 Cells magnetic separation  
 
For isolation of adipose progenitor cells from the stromal vascular fraction (SVF), 
CD117 MicroBeads (Miltenyi Biotec, Minneapolis, MN, USA) were used. CD117, also 
known as c‐ kit, is a stem cell receptor, encoding a 145kD cell surface glycoprotein 
belonging to the class III receptor tyrosine kinase family 
[350]
. According to the 
manufacturer's instructions, cells were trypsinized and resuspended in a specific buffer 
containing phosphate‐ buffered saline (PBS) pH 7.2, 0.5% bovine serum albumin 
(BSA), and 2 mM EDTA. Cells were then incubated with a primary monoclonal anti-
c/kit (CD117) antibody for 1h at 37°C and, after washing, with a secondary antibody 
directly conjugated to MicroBeads for 15 min at 4°C. Then, the cell suspension was 
loaded onto a MACS® Column, which was placed in the magnetic field of a MACS 
Separator. The magnetically labeled CD117+ cells were retained within the column, 
while the unlabeled cells eluted through. After removing the column from the magnetic 
field, the magnetically positively selected CD117+ cells can be eluted in another tube, 
recovered and put in culture for subsequent experiments.  
 
7.3 ADSC characterization by flow cytometry 
 
To evaluate the percentage of mesenchymal markers on isolated population, flow 
cytometry analysis was performed. A total of 1×10
6
 ADSCs were trypsinized, 
centrifuged and fixed in 1% formaldehyde for 10 min at room temperature. After 
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Italy) for 30 min at 4◦C, and then washed and incubated with fluorescein isothiocyanate 
(FITC)- or phycoerythrin (PE)-conjugated primary antibodies for 1h at 4°C.  
ADSCs were tested for CD73-PE, CD90-PE (BD Biosciences, San Jose, CA, USA), 
CD105-PE (Santa Cruz Biotechnology, Heidelberg, Germany), CD45-FITC and CD31-
FTC (Sigma-Aldrich, Munich, Germany) (all at 1 μg/106 cells). After washing, cells 
were analyzed on a flow cytometer (CytoFlex, Beckman Coulter, Milan, Italy) by 
collecting 10,000 events. Cells were positive for CD73, CD90 and CD105, and negative 
for CD31 and CD45 (Table 1). The data analysis was performed using CytExpert 
Software (Beckman Coulter, California, USA). 
 









7.4 ADSC culturing and treatment   
7.4.1 Culture in the presence of melatonin and Vitamin D 
After characterization, ADSCs were grown in a basic medium (BM) and propagated 
until the quantity required to carry out the subsequent in vitro tests has been reached. 
Cells at passage 5 were thus exposed to various treatments. One group of cells, used as 
undifferentiated control, was maintained in a growing (BM). Another group of ADSCs 
was induce to adipogenic differentiation by culturing in a conditioned adipogenic 
differentiation medium (DM or ADM), composed of basic medium supplemented with 
1 μM dexamethasone, 0.5 μM hydrocortisone, 60 μM indomethacine, and 0.5 mM 3-
isobutyl-1-methylxanthine (IBMX Sigma Aldrich Chemie GmbH, Munich, Germany). 
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One group of cells was exposed to differentiation medium in the presence of 0,01M 
melatonin (Melatonin-DM or Melatonin+ADM), or 10
−8





M vitamin D (Vitamin D 10
−6
M-DM), or melatonin plus 10
−8
M 
vitamin D (Melatonin+Vitamin D10
−8
M-DM), melatonin plus 10
−6
M vitamin D 
(Melatonin+Vitamin D 10
−6
M-DM or Melatonin+VitaminD+ADM). As a positive 
control for osteogenic differentiation, a group of ADSCs was cultured in a previously 
described osteogenic differentiation medium (ODM) 
[248]
, containing DMEM (Life 
Technologies Grand Island, NY, USA), 20% FBS (Life Technologies, Grand Island, 
NY, USA), 100 nM dexamethasone, 200 µM L-Ascorbic acid 2-phosphate, 10mM 
betaglycerol2-phosphate (all from Sigma Aldrich Chemie GmbH, Munich, Germany), 
2mM L-glutamine (Euroclone, Milan, Italy), 200 U/mL penicillin-0.1 mg/mL 
streptomycin (Euroclone, Milan, Italy). 
7.4.2 ADSC exposure to natural extracts 
ADSCs at passage 5 were cultured in a basic growing medium in the presence or 
absence of natural Myrtus by-products. Pulp and seeds of this Mediterranean plant, 
residual of industrial liquor production (Industrial by-Product or Ind by-P) or obtained 
in laboratory from fresh fruit (Laboratory by-Product or Lab by-P), were freeze-dried 
and lyophilized. To perform the experiments on cells, the freeze-dried Myrtus extracts 
was suspended in cell basic culturing medium at a final concentration of 0,5 mg/ml. The 
ADSCs were then directly exposed to extracts for 12, 24 and 48h, while control cells 
were cultured in the basic growing medium only. After extracts exposure, cells were 
incubated with 100 μM H2O2 in basic growing medium for 1h, to induce senescence. 
ADSCs cultured with 100 μg/ml ascorbic acid (Sigma-Aldrich, Germany) were used as 
positive control of antioxidant activity and stressful conditions 
[351]
.   
 
7.5 Cell viability assay 
 
Cytotoxicity of Myrtus extracts was evaluated by the Thiazolyl Blue Tetrazolium 
Bromide (MTT) assay (Sigma-Aldrich, Germany). Cells, seeded in 96-well plates at a 
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Myrtus by-Products for 12, 24, and 48 hours. ADSCs were then induced to senescence 
by H2O2 exposure. At the end of incubation, the medium was replaced with 100 μl of 
0.65 mg/ml MTT and cell were incubated for 2h at 37°C.  
After incubation, formazan was dissolved in DMSO and absorbance detected at 570 nm 
using Varian50 MPR, Microplate reader. The viability of H2O2-senescenct cells 
precultured with Myrtus extracts (treated cells) was calculated as % cell viability 
referred to untreated control cells as following formula: (OD570 treated cells) × 
100/(OD570 control). 
7.6 Nitric Oxide Production 
To evaluate the nitric oxide (NO) production after treatment with by-Products and 
induction of senescence, Griess Reagent Kit for Nitrite Determination (Thermo Fisher 
Scientific, USA) was used. ADSCs were seeded in 96-well plate and incubated with 
150 μl of nitrite standard solution for 30 min according to the manufacturer’s protocol. 
The concentration of nitrites at different time point was read in a spectrophotometric 
microplate reader (Varian50 MPR, Microplate reader) as the absorbance at 548 nm 
wavelength of each treated sample referred to control.   
7.7 RNA extraction and gene expression analysis  
Total RNA of control undifferentiated cells and treated ADSCs cultured in the 
previously described conditions, was isolated at each time point, using the 
ChargeSwitch total RNA Cell Kits (Life Technologies, Grand Island, NY, USA), 
according to the manufacturer's protocol, and measured by spectroscopy with Nanodrop 
ND-1000 UV-Vis Spectrophotometer (Nanodrop Technologies, Wilmington, DE). 
Approximately 1 μg of total RNA from each treatment was reverse transcribed in cDNA 
using Superscript Vilo cDNA synthesis kit (Life Technologies USA), according to the 
manufacturer's instructions. Quantitative polymerase chain reaction was performed 
using a CFX Thermal Cycler (Bio-Rad). Amplification was run in 96-well reaction 
plates (Applied Biosystems, Darmstadt, Germany) using Platinum® Quantitative PCR 
SuperMix-UDG Kit (Thermo Fisher Scientific). A 2× SuperMix whit SYBR Green I, 
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were mixed in 25 μL volumes and added to each reaction. The qRT-PCR was 
performed under standard conditions (50 ◦C for 2 min, 95 ◦C for 2 min followed by 40 
cycles of 30 secs at 95°C for denaturation, 30 secs at 60-64 for annealing and 1 min at 
60°C for extension). Each sample was performed in triplicate wells for each gene, 
including endogenous control, a non-template control and distilled water control on the 
same plate. The relative expression of each transcript was determined using target Ct 
values and normalized to GAPDH, considered as a reference gene, while the mRNA 
levels of positive controls and ADSCs treated with the different conditioned media were 
expressed as fold of change (2
-∆∆Ct
) of the mRNA levels observed in undifferentiated 
ADSCs at time 0, define as a control. The qRT-PCR was performed for the following 
genes: octamer-binding transcription factor 4 (Oct-4); Sex determining region Y-box 2 
(Sox2); Homeobox protein Nanog (NANOG); adipocyte fatty acid binding protein 
(aP2); peroxisome proliferator-activated receptor gamma (PPAR-γ); lipoprotein lipase 
(LPL), and acyl-CoA thioesterase 2 (ACOT2); histone deacetylases class I (HDAC1); 
histone deacetylases class III or Sirtuins (SIRT 1 and 2); Stanniocalcin 1 (STC1); 
Osteocalcin (bone gamma-carboxyglutamic acid-containing protein BGLAP); Bone 
morphogenetic protein (BMP2); Interleukin 6 (IL-6); Tumor necrosis factor alpha 
(TNF-α) and Heat Shock Protein 90b (Hsp90b). All primers used, designed using 
“PRIMER BLAST” and “primer3”, spanning all exons and highly specific, were from 
Life Technologies and are reported in Table 2. 
 




GAPDH GAGTCAACGGATTTGGTCGT GACAAGCTTCCCGTTCTCAG 
OCT-4 GAGGAGTCCCAGGCAATCAA CATCGGCCTGTGTATATCCC 
SOX2 CCGTTCATGTAGGTCTCGGAGCTG CAACGGCAGCTACAGCTAGATGC 
NANOG CATGAGTGTGGATCCAGCT CCTGAATAAGCAGATCCAT 
aP2 AGACATTCTACGGGCAGCAC TCATTTTCCCACTCCAGCCC 
PPAR-γ AATCCGTCTTCATCCACAGG GTGAAGACCAGCCTCTTTGC 
LPL CAGGATGTGGCCCGGTTTAT GGGACCCTCTGGTGAATGTG 
ACOT2 GAGGTCTTCACACTGCACCA TCTTGGCCTCGAATGGTATC 
HDAC1 ACTGCTAAAGTATCACCAGAGGGG CACACTTGGCGTGTCCTTTG 
SIRT 1 CATTTTCCATGGCGCTGAGG TGCTGGTGGAACAATTCCTGT 
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STC1 TTCGGAGGTGCTCCACTTTC CAGGCTTCGGACAAGTCTGT 







TNF-α CCTCAGACGCCACAT GAGGGCTGATTAGAGAGA 
Hsp90b AGTTGGAATTCAGGGCATTG TTTCTCGGGAGATGTTCAGG 
 
7.8 Immunofluorescence Microscopy 
ADSCs were induced to differentiation in the presence of various conditioned medium, 
for 21 total days. Cells used as control were cultured in a basic medium to maintain 
their undifferentiated state. At the end of differentiation, cells were trypsinized and cell 
suspension transferred at low density in 8-well chamber slides (BD-falcon). Once 
attached at slide surface, ADSCs were fixed with 100% Methanol (Sigma Aldrich 
GmbH, Germany) at −20 °C for 30 min and then at −80 °C for 30 min and 
permeabilized by 0.1% Triton X-100 (Life Technologies, USA)-PBS. Cells were then 
washed three times in PBS and incubated with 3% Bovine Serum Albumin (BSA)—
0.1% Triton X-100 in PBS (Life Technologies, USA) for 30 min. Primary monoclonal 
antibodies directed against activating signal cointegrator-1 (ASC-1) (Santa Cruz 
Biotechnology, Heidelberg, Germany), proton-coupled amino acid transporter (PAT2) 
(Santa Cruz Biotechnology), and transmembrane protein 26 (TMEM26) (Abcam, 
Cambridge, UK) were added and incubated overnight at 4°C. At the end of incubation, 
after washing step in PBS, ADSCs were incubated with fluorescence-conjugated goat 
anti rabbit IgG or TRITC-conjugated anti mouse secondary antibodies at 37 °C for 1h in 
the dark. Cell nuclei were labelled with 1 μg/mL 4,6-diamidino-2-phenylindole (DAPI). 
All microscopy analyses were performed with a confocal microscope (TCS SP5, Leica, 
Nussloch, Germany).  
7.9 Red Oil O and Alizarin Red staining  
To evaluate cell differentiation processes, ADSCs cells were cultured for 21 days on 
tissue culture 24-wells plate (BD-falcon) in the presence of different conditioned media 
or basic growing medium for undifferentiated control. For adipogenic differentiation, 




Exploring stem cell fate from adipose tissue: novel approaches to modulate stem cell signatures. 
Dottorato in Scienze Biomediche, Curriculum Fisiopatologia Medica, Università degli Studi di 
Sassari. 
 








in H2O and in 60% isopropanol. ADSCs were stained with Oil red O solution for 15 
min and after a washing step in H2O, counterstained for 2 min in Mayer’s hematoxylin 
solution (Sigma Aldrich GmbH, Germany).  
The level of adipogenic differentiation was evaluated by light microscopy and analysis 
of lipid accumulation was performed using image analysis software (ImageJ, National 
Institutes of Health, USA), using mature adipocytes as a positive control.  
For osteogenic differentiation cells were fixed with 10% formalin for 15 min at RT. 
After three washing steps in distilled water (ddH2O), ADSCs were stained with 2% 
alizarin red S solution (Santa Cruz Biotechnology) for 20 min at RT. To avoid the 
excess of solution, cells were then washed several times with ddH2O and finally 
observed under a light microscope (Leica, Nussloch, Germany). Cytoplasmatic calcium 
deposition was analyzed using ImageJ (ImageJ, National Institutes of Health, USA), 
using cells cultured in osteogenic differentiation medium as positive control of 
osteogenic phenotype.  
 
7.10 Senescence Associated β-galactosidase Staining 
 
The number of senescent cells in culture was evaluated by the Senescence Cells 
Histochemical Staining Kit (Sigma-Aldrich, Germany). ADSCs plated in 6-well plate 
were cultured in the presence or absence of Myrtus extracts for 12, 24 and 48h, and then 
senescence was induced by exposure to H2O2. At each time point, the cells were fixed 
and stained with X-gal Solution according to the manufacturer's instructions. Cells were 
then incubated overnight at 37°C and finally observed by light microscope (Leica, 
Nussloch, Germany). SA-β-Gal activity and the number of relative positively blue-
stained cells was calculated as the percentage of total number of cells using ImageJ 
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7.11 Statistical Analysis  
Statistical analysis was performed using Statistical Package for the Social Sciences 
version 13 software (SPSS Inc., Chicago, IL, USA). Non-parametric Kruskal-Wallis 
rank sum and Wilcoxon signed-rank test were applied to evaluate the distributions and 
homogeneity of each group variance at different times of observation, assuming p value 
<0.05 as statistically significant. The first was used to detect differences between 
treatments, while the second was applied to evaluate, in the same group, differences 
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8.1 Features of ADSCs after treatment with conditioned media  
Changes in morphology of ADSCs was evaluated by optical microscopy after 21 days 
of exposure to melatonin and vitamin D conditioned media. Melatonin+vitamin D-
treated cells showed a significant different morphology as compared to both cells 
cultured in adipogenic medium (ADM) alone, exhibiting a morphology typical of 
mature adipocytes, and with untreated control cells, culturing in a basic growing 
medium (BM) (Figure 9). 
8.2 Biomolecules maintain cell viability reducing nitric oxide production 
after H2O2 exposure 
Thiazolyl Blue Tetrazolium Bromide (MTT) assay was used to evaluate cell metabolic 
activity after extracts exposure and senescence initiation. The extracts tested showed no 
cytotoxicity in cells, nevertheless a slight increase in cell viability after H2O2 exposure 
was observed (Figure 10). Myrtus biomolecules preserved the viability of cells exposed 
to stressor events for all the evaluated time points, maintaining their mitochondrial 
activity, as compared to not pre-treated control cells. Moreover, Myrtus extracts showed 
an important antioxidant activity, able to significantly counteract the production of 
nitric oxide after a strong oxidative stress, as the exposure to H2O2. The NO production 
was considerably reduced after 12 and 24h of treatment with extracts, as compared to 
control cells. This decrease was maintained even after 48h of Myrtus exposure, although 
being statistically not significant (Figure 11). 
8.3 Modulation of stem cells regenerative potential in inflammatory 
response 
ADSCs exposure to Myrtus extracts was able to significantly decrease the expression of 
proinflammatory cytokines, induced by H2O2 stressor, as compared to untreated cells. 




Exploring stem cell fate from adipose tissue: novel approaches to modulate stem cell signatures. 
Dottorato in Scienze Biomediche, Curriculum Fisiopatologia Medica, Università degli Studi di 
Sassari. 
 








significantly downregulation after 12h of treatment (Figure 12) while, being induced for 
longer period of treatment.  
This result could be explained considering the ability of this cytokine to stimulate 
regenerative properties of stem cells by their recruitment at the injured site. Moreover, 
also stem cell plasticity was implemented, as demonstrated by the upregulation of the 
stemness related genes Oct-4, Sox2 and NANOG upon Myrtus exposure (Figure 13). 
 
8.4 Cellular response to stress and cell differentiation involve Sirtuin-
Dependent Epigenetic Changes  
Cellular response to oxidative stress damages is associated with increased levels of 
HSP90b and SIRT1 mRNA (Figure 14), protecting cells from a premature senescence. 
Moreover, this upregulation in Sirt1 and 2 gene expression could also be observed 
during stem cell differentiation. HDAC1 and Sirtuins were significantly upregulated in 
cells exposed to the adipogenic medium in the presence of melatonin, reaching a 
maximum after 21 days in culture (Figure 15). This effect was further highlighted when 
cells were cultured in the presence of both melatonin and vitamin D, as compared to 
cells exposed to the adipogenic medium alone. In addition, also cells cultured in the 
presence of the classical osteogenic medium exhibited the same trend (Figure 15), 
demonstrating a role of the epigenetic regulators HDAC1 and Sirtuins in stem cell 
osteogenic differentiation.  
8.5 Melatonin and vitamin D counteract adipogenesis inducing the 
molecular pattern of osteogenesis 
The combination of the two molecules modulated the expression of the main adipogenic 
markers during ADSCs differentiation. ADSCs exposed to the adipogenic medium 
showed an upregulation of PPAR-γ expression after 7, 14 and 21 days of culturing, 
while the expression of the same gene significantly decreased in cells cultured in the 
same adipogenic medium plus vitamin D or melatonin or both (Figure 16). AP2 was 
also actively expressed in cells exposed to adipogenic differentiation medium, showing 
a significant downregulation when the two molecules were added to the same medium 
(Figure 16). LPL and ACOT2 showed the same trend (Figure 16). Interestingly, ADSCs 
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BGLAP and BMP2 that were induced when cells were cultured in the same medium but 
in the presence of melatonin and/or vitamin D (Figure 17).  
Similar results were obtained for the adipogenic-related genes ACOT2, LPL and 
TMEM26.  
The expression of these genes was induced when ADSCs were cultured for 21 days in 
the presence of the adipogenic differentiation medium alone, while was significantly 
inhibited in the presence of melatonin and vitamin D in the same medium (Figures 18-
20). 
 
8.6 Melatonin and vitamin D inhibit intracellular lipid accumulation 
inducing ADSCs mineralization  
 
Consistent with gene expression analysis, ADSCs exposure to the adipogenic 
differentiation medium induced intracellular lipid accumulation, that was counteracted 
in the presence of melatonin or vitamin D (Figure 21). Fat droplet formation was 
inhibited when melatonin and vitamin D were added simultaneously to the adipogenic 
differentiation medium, while cytosolic calcium accumulation was induced (Figure 21). 
The mineralization process was absent in cells grown in an adipogenic differentiation 
medium alone, while appearing particularly in cells exposed to the same medium plus 
melatonin and vitamin D, and being superimposable to what observed in cells cultured 
with the classic osteogenic differentiation medium (Figure 22).  
 
8.7ADSCs survive to premature senescence induced by oxidative stress 
 
ADSCs treated with Myrtus by-Products counteracted premature senescence induced by 
H2O2 exposure, as shown by the number of blue senescent cells. The extracts are able to 
protect cells from oxidative stress damages, significantly counteracting the senescence 
process (Figure 23). β-gal analysis revealed that this antisenescence activity of extracts 
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The human body possesses the ability to resist to various environmental stressors, by 
activating adaptation mechanisms responsible for restoring the physiological 
homeostasis 
[352][353]
. Variations in biological processes lead to pathological condition as 
aging, diabetes, cardiovascular diseases and cancer 
[354][355]
. Inflammation is one of the 
first biological responses against injuries, essential for protecting tissue integrity and 
functionality 
[313]
. Oxidative stress could be responsible for activating inflammatory 
response, along with pro-inflammatory cytokine secretion and premature cellular 
senescence 
[356]
. Endogenous biological systems are able to balance ROS production 
and modulate cellular responses to increase physiological defense processes and cell 
survival 
[357]
. When this regulation system is compromised, the body loses its ability to 
counteract stress, leading to irreversible organ and tissue damages 
[358]
. Natural 
compounds, as flavonoids and anthocyanins also known as phytochemicals, can directly 
interact with endogenous antioxidant responses, showing anticancer properties and 
protection against several disorders 
[359]–[361]
. These molecules show immunomodulatory 
properties, able to counteract the synthesis of enzymes involved in ROS production 
[362][363]
. Myrtus contains a large amount of these compounds in its berries that can be 
employed in reducing inflammation, oxidative stress, also protecting cells from 
premature senescence
[308], [309][364][365]
. The pretreatment of ADSCs with different Myrtus 
by-Products decreased the production of nitric oxide after oxidative stress induction 
(Figure 11) and significantly downregulated the expression of TNF-α and IL-6 in the 
first hours of H2O2 exposure (Figure 12). On the other hand, pro-inflammatory 
cytokines release is crucial in promoting tissue regeneration through stem cell 
recruitment 
[366][367]
. Myrtus extracts promote tissue regeneration, through modulation of 
TNF-α and IL-6 levels and above all increasing the expression of stemness markers. In 
fact, Oct-4, Sox2, and NANOG showed a significative upregulation in ADSCs exposed 
to Myrtus treatment, as compared to control untreated cells (Figure 13). In addition, the 
treatment with the extracts increased the levels of Hsp90b expression (Figure 14), 
involved in maintenance of mitochondrial activity and cell viability in stressing 
conditions 
[368]
. The upregulation of the pluripotency markers is strictly related to the 
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14) being also involved in cellular stress and inflammatory responses 
[369]
. Furthermore, 
the NAD-dependent protein deacetylase SIRT1 is associated with regulation of stem 
cell differentiation processes 
[370]
, by inhibiting PPAR-γ expression and the appearance 
of an adipogenic phenotypes 
[371]
. During adipogenesis, PPAR-γ was significantly 
upregulated in ADSCs cultured in the presence of adipogenic differentiation medium, as 
compared to control untreated cells (Figure 16), while the presence of melatonin and 
vitamin D interfered with its expression, committing cells to the osteogenic 
phenotype (Figure 17). Epigenetic modulators are frequently used to orchestrate stem 
cell fate 
[233][237]
. Butyric acid, in combination with retinoic and hyaluronic acids, is able 
to inhibit HDAC expression, inducing stem cells differentiation toward a cardiac 
phenotype 
[247], [372], [373]
. HDAC class 1 is involved in the establishment of a specific 
stem cell fate, while  maintaining stem pluripotency upon inhibition 
[374]
. During the 
first three days of culturing according to the above described conditions (adipogenic 
conditioned media with melatonin and vitamin D), ADSCs showed a downregulation of 
HDAC1 (Figure 15), that was then upregulated from 7 to 21 days of culturing in the 
presence of adipogenic differentiation medium and the combination of melatonin and 
vitamin D (Figure 15). These changes in HDAC1 level of expression is related to the 
appearance of an osteogenic phenotype, despite the presence of the adipogenic 
conditioned medium. Our results can explain the establishment of an adipogenic 
commitment during the first days of treatment, followed by a loss of stemness and the 
appearance of an osteogenic phenotype at the end of the differentiation process, as 
described also by other authors 
[375]
. The presence of melatonin and vitamin D in the 
adipogenic medium is able to counteract intracellular lipid accumulation and 
adipogenesis (Figure 21), inducing osteogenesis, as revealed by alizarin red assay 
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Figure 6. Bioactive molecules modulate stem cell fate inducing epigenetic modifications and 





Bioactive molecules can influence stem cell behavior modulating gene expression, and 
cellular mechanisms responsible for pluripotency and differentiation. It is also 
demonstrated that ADSCs retain a sort of memory of their belonging tissue, able to 
drive their fate 
[376][377]
. Understanding the molecular mechanisms involved in the 
decision of this fate could lead to the development of drugs capable of influencing stem 
cell behavior, for in vivo clinical applications 
[28]
. These results described for the first 
time a direct association between melatonin and vitamin D and epigenetic modulators in 
driving stem cell commitment, thus highlighting novel specific tools for stem cell 
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Figure 7. The balance between osteogenesis and apipogenesis involves epigenetic modification 
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Figure 8. Isolation from adipose tissue. Adipose tissue (A-B) was mechanically fragmented (C) 
and digested in a solution of Collagenase I. After centrifugation (D), the SVF was put in culture 
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Figure 9. Analysis of cell morphology after culturing in conditioned medium 
[256]
. Cell 
morphology changed in the presence of melatonin (Melatonin+ADM) or melatonin and 
vitamin D (Melatonin+VitaminD+ADM) Control cells were maintained in basic medium 
(BM) while adipogenesis was induce in the presence of differentiation medium alone (ADM). 
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Figure 10. Cell viability assay by MTT 
[309]
. Cell viability of treated cells was expressed as 
percentage of control cells, considered as 1. Data were analyzed using SPSS version 13 and are 
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Figure 11. NO concentration after inducing oxidative stress 
[309]
 was evaluated in cells 
pretreated with Myrtus extracts (yellow and red bars), as compared to untreated senescent cells 
(black bars). Positive control for antioxidant activity were cells exposed to ascorbic acid (blue 
bars).  The concentration of NO was read at 548 nm and expressed as mean± SD assuming p ≤ 
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Figure 12. Gene expression levels of proinflammatory cytokines 
[309]
. The expression of IL-6 
(a) and TNF- α (b) was evaluated in cells pretreated with the extracts as compared to control 
cells (black bars). The mRNA levels for each gene were expressed as fold of change (2
−∆∆Ct
) of 
mRNA levels of control ADSCs, defined as 1 and normalized to Glyceraldehyde-3-Phosphate-
Dehidrogenase (GAPDH). Data are expressed as mean± SD assuming p ≤ 0.05 (*) as 
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Figure 13. Gene expression levels of stemness related genes 
[309]
. The expression of Oct-4 (a), 
Sox2 (b) and NANOG (c) was evaluated in cells pretreated with the extracts as compared to 
control cells (black bars). The mRNA levels for each gene were expressed as fold of change 
(2
−∆∆Ct
) of mRNA levels of control ADSCs, defined as 1 and normalized to Glyceraldehyde-3-
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Figure 14. Gene expression levels of SIRT and HSP 
[309]
. The expression of SIRT1 (a) and 
Hsp90b (b) was evaluated in cells pretreated with the extracts as compared to control cells 
(black bars). The mRNA levels for each gene were expressed as fold of change (2
−∆∆Ct
) of 
mRNA levels of control ADSCs, defined as 1 and normalized to Glyceraldehyde-3-Phosphate-
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Figure 15. Gene expression levels of SIRT and HDAC in adipogenic conditioned medium 
[256]
. 
The expression of HDAC1 (A), SIRT1 (B) and SIRT2 (C) was evaluated in cells cultured in the 
presence of melatonin (yellow bars) or in differentiation medium with melatonin and vitamin D 
(red bars), as compared to control untreated cells (black bars). Positive control for osteogenesis 
were ADSCs cultured in osteogenic medium (blue bars). The mRNA levels for each gene were 
expressed as fold of change (2
−∆∆Ct
) of mRNA levels of control ADSCs (black bars). defined as 
1 and normalized to Glyceraldehyde-3-Phosphate-Dehidrogenase (GAPDH). Data are expressed 
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Figure 16. Gene expression levels of adipogenic related genes 
[255]
. mRNA levels or PPAR γ 
(A), aP2 (B) LPL (C) and ACOT2 (D) were evaluated in cells cultured in the presence of 
different conditioned media, as compared to control untreated cells (red bars). Positive control 
for adipogenesis were ADSCs cultured in adipogenic medium (red bars). The mRNA levels for 
each gene were expressed as fold of change (2
−∆∆Ct
) of mRNA levels of control ADSCs (white 
bars) defined as 1 and normalized to Glyceraldehyde-3-Phosphate-Dehidrogenase (GAPDH). 
Data are expressed as mean± SD assuming p ≤ 0.05 (*) as statistically significant. Significant 
difference from the differentiation medium is marked by red asterisks, while significant 
difference from mature adipocytes (black bars) is marked by black asterisks (* p ≤ 0.05, ** p ≤ 
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Figure 17. Gene expression levels of osteogenic related genes 
[256]
. The expression of STC1(A), 
BGLAP (B) and BMP2 (C) was evaluated in cells cultured in the presence of melatonin (yellow 
bars) or in differentiation medium with melatonin and vitamin D (red bars), as compared to 
control untreated cells (black bars). Positive control for osteogenesis were ADSCs cultured in 
osteogenic medium (blue bars). The mRNA levels for each gene were expressed as fold of 
change (2
−∆∆Ct
) of mRNA levels of control ADSCs (black bars). defined as 1 and normalized to 
Glyceraldehyde-3-Phosphate-Dehidrogenase (GAPDH). Data are expressed as mean± SD 
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Figure 18. Immunohistochemical analysis of adipogenic related proteins 
[255]
. Expression of 
TMEM26 was evaluated in cells cultured in the presence of different conditioned media. Nuclei 
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Figure 19. Immunohistochemical analysis of adipogenic related proteins 
[255]
. Expression of 
ASC-1 was evaluated in cells cultured in the presence of different conditioned media. Nuclei 
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Figure 20. Immunohistochemical analysis of adipogenic related proteins 
[255]
. Expression of 
PAT2 was evaluated in cells cultured in the presence of different conditioned media. Nuclei 
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Figure 21. Evaluation of lipid accumulation 
[255]
. Lipid accumulation during adipose 
differentiation (A) was evaluated in ADSCs cultured in the presence of different conditioned 
media after 21 days. Scale bar=100 μm. The amount of lipid droplets was calculated using 
ImageJ (B). Positive control were mature adipocytes (black bars), while negative control for 
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Figure 22. Evaluation of calcium accumulation 
[256]
. Mineralization during differentiation (A) 
was evaluated in ADSCs cultured in the presence of different conditioned media after 21 days. 
Positive control (CTRL+) for osteogenesis are ADSCs cultured in osteogenic conditioned 
medium. Scale bar=100 μm. The percentage of mineralization was calculated using ImageJ 
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Figure 23. β-galactosidase activity [309]. Senescence-associated β-gal (A) was evaluated in cells 
pretreated with Myrtus extracts (yellow and red bars), as compared to untreated senescent cells 
(black bars). Positive control for antioxidant activity were cells exposed to ascorbic acid (blue 
bars). Scale bar=100 μm. The number of senescent (blue) cells was calculated as the percentage 
of SA-β-Gal-positive cells for each treatment relative to the total number of cells counted using 
ImageJ software analysis. Data were expressed as mean± SD assuming p ≤ 0.05 (*) as 
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